Patnaik, Rajashree
Varghese, Riah
Jannati, Shirin
Naidoo, Nerissa
Banerjee, Yajnavalka
Funding for this research was provided by:
Mohammed Bin Rashid University of Medicine and Health Sciences (MBRUCM-RG-2022-04)
Article History
Received: 26 March 2024
Accepted: 20 September 2024
First Online: 1 October 2024
Declarations
:
: The experimental procedures in this research were carried out in vitro and did not entail the utilization of animal models, patient samples, or human subjects. As a result, the study presented minimal risk and falls within one of the exempt review categories outlined by the institutional review board (IRB) regulations at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU). For additional details and clarification, inquiries can be directed to the MBRU IRB at irb@mbru.ac.ae. The study exclusively utilized in vitro experiments with readily available cell lines, eliminating the involvement of human subjects. It is essential to highlight that no individuals under the age of 18 were part of the study, rendering parental or guardian consent unnecessary. The experiments conducted did not include any form of direct or indirect interaction with human subjects. It’s crucial to emphasize that our research did not require access to medical records or archived samples. In summary, our study focused on in vitro experiments using commercially acquired cell lines and did not entail the participation of human subjects. Consequently, participant consent was not deemed necessary, and the requirement for consent was waived.
: Not Applicable.
: The authors declare no competing interests.
: Not Applicable.